Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Kidney Int. 2019 Feb;95(2):268-280. doi: 10.1016/j.kint.2018.10.018.

Abstract

The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline's publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.

Keywords: IgA nephropathy; KDIGO; hypertension; kidney biopsy; membranous nephropathy; proteinuria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biopsy
  • Consensus Development Conferences as Topic
  • Disease Progression
  • Glomerular Filtration Rate
  • Glomerulonephritis, IGA / pathology
  • Glomerulonephritis, IGA / physiopathology
  • Glomerulonephritis, IGA / therapy*
  • Glomerulonephritis, Membranous / pathology
  • Glomerulonephritis, Membranous / physiopathology
  • Glomerulonephritis, Membranous / therapy*
  • Humans
  • Kidney Glomerulus / pathology
  • Kidney Glomerulus / physiopathology
  • Nephrology / methods
  • Nephrology / standards
  • Nephrosis, Lipoid
  • Practice Guidelines as Topic*
  • Renal Insufficiency, Chronic / pathology
  • Renal Insufficiency, Chronic / physiopathology
  • Renal Insufficiency, Chronic / prevention & control*
  • Risk Factors
  • Treatment Outcome